Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 136.78%41.12M | 92.22%16.98M | 1,647.12%8.79M | 4.61M | 10.73M | -24.92%17.36M | 8.83M | 503K | 28.79%23.13M | 447.67%17.96M |
| Net profit before non-cash adjustment | 34.68%75.9M | 72.02%23.71M | 39.03%17.61M | --16.54M | --18.03M | 101.41%56.35M | --13.79M | --12.67M | 340.32%27.98M | 256.78%6.35M |
| Total adjustment of non-cash items | -0.27%11.91M | 38.10%3.69M | -4.83%3.35M | --1.96M | --2.91M | 200.32%11.94M | --2.67M | --3.52M | 74.43%3.98M | 8.49%2.28M |
| -Depreciation and amortization | 15.51%8.68M | 41.16%2.73M | 8.36%2.04M | --1.96M | --1.95M | 355.29%7.51M | --1.93M | --1.88M | 72.09%1.65M | -25.12%959.03K |
| -Reversal of impairment losses recognized in profit and loss | --30K | --0 | --6K | --0 | --24K | --0 | --0 | --0 | --0 | 805.71%104.84K |
| -Assets reserve and write-off | --50.33K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | 109.97%61.2K | -419.27%-613.83K |
| -Disposal profit | 1,491.74%29.86K | 1,491.74%29.86K | --0 | --0 | --0 | 558.68%1.88K | --1.88K | --0 | 99.54%-409 | ---88.09K |
| -Net exchange gains and losses | -54.52%488.09K | 184.70%214.09K | -98.03%16K | --272K | ---14K | 117.48%1.07M | ---252.75K | --812K | 695.79%493.49K | -15,707.25%-82.83K |
| -Other non-cash items | -20.60%2.66M | -29.72%694.27K | 55.85%1.29M | ---274K | --949K | 89.22%3.35M | --987.91K | --829K | -11.44%1.77M | 224.21%2M |
| Changes in working capital | 8.32%-46.69M | -36.72%-10.42M | 22.38%-12.18M | ---13.89M | ---10.21M | -477.01%-50.93M | ---7.62M | ---15.69M | -194.65%-8.83M | 203.07%9.33M |
| -Change in receivables | -69.02%-50.49M | -151.23%-36.35M | 63.00%-3.12M | ---4.42M | ---6.61M | -216.75%-29.87M | ---14.47M | ---8.42M | 1,396.92%25.59M | 3.31%-1.97M |
| -Change in inventory | 30.12%-1.78M | 296.55%13.82M | -163.88%-4.36M | ---15.29M | --4.06M | 84.42%-2.55M | --3.49M | ---1.65M | -426.94%-16.34M | -33.59%5M |
| -Change in payables | 130.14%5.58M | 260.30%12.1M | 16.29%-4.7M | --5.83M | ---7.66M | -15.92%-18.51M | --3.36M | ---5.61M | -353.47%-15.97M | 143.34%6.3M |
| -Changes in other current assets | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---2.1M | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -113.97%-5.19M | -104.43%-1.58M | -198.04%-1.82M | -1.04M | -759K | -39.12%-2.43M | -770.52K | -611K | 15.25%-1.74M | -206.32%-2.06M |
| Interest received (cash flow from operating activities) | 1,961.53%2.99M | 2,904.64%721.44K | 1,680.00%712K | 1.52M | 37K | -3.49%145.01K | 24.01K | 40K | 60.07%150.25K | -44.44%93.87K |
| Tax refund paid | -116.60%-20.89M | 36.86%-4.17M | -205.36%-3.93M | -3.95M | -8.84M | -315.96%-9.64M | -6.61M | -1.29M | -4,189.99%-2.32M | -39.24%-54.05K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 231.42%18.02M | 707.33%11.96M | 376.68%3.75M | --1.15M | --1.17M | -71.70%5.44M | --1.48M | ---1.36M | 20.55%19.22M | 379.28%15.94M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -114.70%-15.35M | -351.92%-7.78M | -1,565.74%-7.2M | ---337K | ---43K | -957.24%-7.15M | ---1.72M | ---432K | -258.18%-676.37K | 2,671.85%427.6K |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---47M | ---- | ---- | ---- | ---- |
| Investing cash flow | -114.70%-15.35M | -351.92%-7.78M | -1,565.74%-7.2M | ---337K | ---43K | -957.24%-7.15M | ---1.72M | ---432K | -258.18%-676.37K | 2,671.85%427.6K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -4.00%19.65M | -897.10%-69.64M | 1,055.13%44.61M | --43.97M | --704K | 340.34%20.47M | --8.74M | ---4.67M | -32.50%4.65M | 13.53%6.89M |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --98.5M | ---363 | --98.5M | --0 | --0 |
| Increase or decrease of lease financing | -14.54%-6.69M | -26.82%-2.23M | -31.20%-1.6M | ---1.57M | ---1.29M | -597.42%-5.84M | ---1.76M | ---1.22M | -12.13%-837.49K | -38.56%-746.86K |
| Interest paid (cash flow from financing activities) | 6.38%-1M | -58.74%-383.19K | 28.29%-185K | ---206K | ---227K | -515.92%-1.07M | ---241.4K | ---258K | -59.99%-173.63K | 46.88%-108.53K |
| Financing cash flow | -89.33%11.96M | -1,172.46%-72.25M | -53.62%42.83M | --42.19M | ---813K | 2,980.90%112.06M | --6.74M | --92.35M | -39.69%3.64M | 13.32%6.03M |
| Net cash flow | ||||||||||
| Beginning cash position | 212.96%162M | 57.52%244.65M | 216.17%205.28M | --162.31M | --162M | 73.93%51.76M | --155.32M | --64.93M | 308.83%29.76M | -5.23%7.28M |
| Current changes in cash | -86.74%14.63M | -1,147.77%-68.07M | -56.51%39.38M | --43M | --317K | 397.58%110.35M | --6.5M | --90.57M | -0.99%22.18M | 5,672.55%22.4M |
| Effect of exchange rate changes | -138.28%-269.58K | -220.29%-223.58K | 93.30%-12K | ---32K | ---2K | 35.06%-113.13K | --185.87K | ---179K | -310.34%-174.22K | 15,707.25%82.83K |
| End cash Position | 8.86%176.35M | 8.86%176.35M | 57.52%244.65M | --205.28M | --162.31M | 212.96%162M | --162M | --155.32M | 73.93%51.76M | 308.83%29.76M |
| Free cash flow | 254.80%2.67M | 1,853.00%4.18M | -92.89%-3.45M | --808K | --1.13M | -109.30%-1.72M | ---238.35K | ---1.79M | 17.48%18.54M | 375.67%15.78M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.